Eligibility Relapsing Forms of Multiple Sclerosis NCT02097849

Criteria
Description

Criteria

must have a confirmed diagnosis of rrms per the 2010 mcdonald criteria.
Description

confirmed diagnosis of rrms

Data type

boolean

Alias
UMLS CUI [1]
C0751967
must have a known tetanus immunization history with most recent tetanus vaccination given 2 to 15 years prior to screening and an anti-tetanus igg titer at screening that is less than or equal to one-half the upper limit of detection for the assay.
Description

tetanus immunization

Data type

boolean

Alias
UMLS CUI [1]
C0199807
UMLS CUI [2]
C0305058
must have been on a stable approved dose of tecfidera (240 mg twice daily [bid]) [group 1] for ≥6 months or on a stable approved dose of a non-pegylated ifn (e.g., avonex, betaseron, rebif, extavia) [group 2] for ≥3 months prior to day 1.
Description

Tecfidera | Avonex | Betaseron | Rebif | Extavia

Data type

boolean

Alias
UMLS CUI [1]
C3556178
UMLS CUI [2]
C0594372
UMLS CUI [3]
C0284968
UMLS CUI [4]
C0752980
UMLS CUI [5]
C2719461
Exclusion criteria
Description

Exclusion criteria

clinical relapse requiring treatment within 30 days prior to day 1.
Description

clinical relapse requiring treatment

Data type

boolean

Alias
UMLS CUI [1,1]
C0856120
UMLS CUI [1,2]
C0815189
pneumococcal vaccination within 5 years prior to screening.
Description

pneumococcal vaccination; screening

Data type

boolean

Alias
UMLS CUI [1]
C0419707
previous exposure to meningococcal vaccines.
Description

meningococcal vaccines; exposure

Data type

boolean

Alias
UMLS CUI [1]
C0700144
UMLS CUI [2]
C0332157
known hypersensitivity to td, ppsv23, or mcv4 or their components.
Description

hypersensitivity to td, ppsv23, or mcv4 or their components.

Data type

boolean

Alias
UMLS CUI [1,1]
C0020517
UMLS CUI [1,2]
C3272755
UMLS CUI [2,1]
C0020517
UMLS CUI [2,2]
C0358314
note: other protocol-defined inclusion/exclusion criteria may apply.
Description

other protocol-defined inclusion/exclusion criteria may apply

Data type

boolean

Alias
UMLS CUI [1]
C2827031

Similar models

Eligibility Relapsing Forms of Multiple Sclerosis NCT02097849

Name
Type
Description | Question | Decode (Coded Value)
Data type
Alias
Item Group
confirmed diagnosis of rrms
Item
must have a confirmed diagnosis of rrms per the 2010 mcdonald criteria.
boolean
C0751967 (UMLS CUI [1])
tetanus immunization
Item
must have a known tetanus immunization history with most recent tetanus vaccination given 2 to 15 years prior to screening and an anti-tetanus igg titer at screening that is less than or equal to one-half the upper limit of detection for the assay.
boolean
C0199807 (UMLS CUI [1])
C0305058 (UMLS CUI [2])
Tecfidera | Avonex | Betaseron | Rebif | Extavia
Item
must have been on a stable approved dose of tecfidera (240 mg twice daily [bid]) [group 1] for ≥6 months or on a stable approved dose of a non-pegylated ifn (e.g., avonex, betaseron, rebif, extavia) [group 2] for ≥3 months prior to day 1.
boolean
C3556178 (UMLS CUI [1])
C0594372 (UMLS CUI [2])
C0284968 (UMLS CUI [3])
C0752980 (UMLS CUI [4])
C2719461 (UMLS CUI [5])
Item Group
Exclusion criteria
clinical relapse requiring treatment
Item
clinical relapse requiring treatment within 30 days prior to day 1.
boolean
C0856120 (UMLS CUI [1,1])
C0815189 (UMLS CUI [1,2])
pneumococcal vaccination; screening
Item
pneumococcal vaccination within 5 years prior to screening.
boolean
C0419707 (UMLS CUI [1])
meningococcal vaccines; exposure
Item
previous exposure to meningococcal vaccines.
boolean
C0700144 (UMLS CUI [1])
C0332157 (UMLS CUI [2])
hypersensitivity to td, ppsv23, or mcv4 or their components.
Item
known hypersensitivity to td, ppsv23, or mcv4 or their components.
boolean
C0020517 (UMLS CUI [1,1])
C3272755 (UMLS CUI [1,2])
C0020517 (UMLS CUI [2,1])
C0358314 (UMLS CUI [2,2])
other protocol-defined inclusion/exclusion criteria may apply
Item
note: other protocol-defined inclusion/exclusion criteria may apply.
boolean
C2827031 (UMLS CUI [1])